Emcure Pharmaceuticals Limited — Atazanavir Exporter Profile
Indian Pharmaceutical Exporter · #2 for Atazanavir · $8.3M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #2 Indian exporter of Atazanavir with $8.3M in export value and 159 verified shipments. Emcure Pharmaceuticals Limited holds a 11.2% market share in Atazanavir exports across 48 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Atazanavir Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Atazanavir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $550.0K | 12 | 11.3% |
| KENYA | $408.8K | 13 | 8.4% |
| MYANMAR | $350.0K | 7 | 7.2% |
| ALGERIA | $322.2K | 25 | 6.6% |
| BURUNDI | $300.0K | 6 | 6.2% |
| ZIMBABWE | $300.0K | 6 | 6.2% |
| ETHIOPIA | $250.0K | 5 | 5.1% |
| MOZAMBIQUE | $200.0K | 4 | 4.1% |
| SIERRA LEONA | $150.0K | 3 | 3.1% |
| MALAYSIA | $146.5K | 8 | 3.0% |
Emcure Pharmaceuticals Limited exports Atazanavir to 53 countries. The largest destination is SOUTH AFRICA accounting for 11.3% of Emcure Pharmaceuticals Limited's Atazanavir shipments, followed by KENYA (8.4%) and MYANMAR (7.2%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atazanavir from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EMCURE PHARMACEUTICALS SA (PTY) LTD | SOUTH AFRICA | $300.0K | 7 |
| PROGRAMME DES NATIONS UNIES POUR LE | BURUNDI | $300.0K | 6 |
| UNITED NATIONS OFFICE FOR PROJECT | MYANMAR | $300.0K | 6 |
| MINISTRY OF HEALTH AND CHILD CARE | ZIMBABWE | $300.0K | 6 |
| PHARMACIE CENTRALE DES HOPITAUX, | ALGERIA | $263.1K | 18 |
| ETHIOPIAN PHARMACEUTICAL SUPPLY SER | ETHIOPIA | $250.0K | 5 |
| UNITED NATIONS DEVELOPMENT PROGRAMM | DJIBOUTI | $219.9K | 6 |
| NATIONAL MEDICAL STORES | KENYA | $200.0K | 4 |
| NATIONAL HIV/AIDS CONTROL PROGRAM | SIERRA LEONA | $150.0K | 3 |
| EMCURE PHARMACEUTICALS SA (PTY) LIMITED | SOUTH AFRICA | $150.0K | 3 |
Emcure Pharmaceuticals Limited supplies Atazanavir to 67 buyers globally. The largest buyer is EMCURE PHARMACEUTICALS SA (PTY) LTD (SOUTH AFRICA), followed by PROGRAMME DES NATIONS UNIES POUR LE (BURUNDI) and UNITED NATIONS OFFICE FOR PROJECT (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atazanavir Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $22.4M worth of Atazanavir through 473 shipments from 17 suppliers to 88 countries, serving 199 buyers globally. Emcure Pharmaceuticals Limited contributes $8.3M to this total, accounting for 11.2% of India's Atazanavir exports. Emcure Pharmaceuticals Limited ships Atazanavir to 53 countries through 67 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Atazanavir Exports?
Emcure Pharmaceuticals Limited's average Atazanavir shipment value is $52.5K per consignment, based on 159 shipments totaling $8.3M. The largest destination is SOUTH AFRICA (11.3% of Emcure Pharmaceuticals Limited's Atazanavir exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Atazanavir Exporters?
Emcure Pharmaceuticals Limited ranks #2 among 17 Indian Atazanavir exporters with a 11.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($11.3M), EMCURE PHARMACEUTICALS LIMITED ($8.0M), HETERO LABS LIMITED ($2.1M). Emcure Pharmaceuticals Limited processed 159 shipments to 48 destination countries.
What Atazanavir Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - ATAZOR R 300/100MG TABLET 30S WTC( ATAZANAVIR & RITONAVIR USP TABLETS 300 | $300.0K | 6 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS):- RITOATAZ 300/100 MG TABLET 30S ( ATAZANAVIR & RITONAVIR USP TABLETS 300/100MG | $300.0K | 6 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM : ATAZOR R 300/100MG TABLET 30S ATAZANAVIR & RITONAVIRTABLETS 300/100MG | $200.0K | 4 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS)- ATAZOR R 300/100MG TABLET 30S WTC ( ATAZANAVIR & RITONAVIR USP TABLETS 300/10 | $200.0K | 4 |
| ATAZOR R 300/100MG TABLETS (ATAZANAVIR 3 | $167.9K | 6 |
| ATAZOR R 300/100MG TABLETS(ATAZANAVIR 30 | $152.7K | 4 |
| PHARMACEUTICALS PRODUCTS (FINISHED PRODUCT GENERIC NAME) ATAZOR R 300/100MG TABLET 30S WTC ( ATAZANAVIR & RITONAVIR USPPCS | $150.0K | 3 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) RITOATAZ 300/100 MG TABLET 30S (ATAZANAVIR & RITONAVIR USP TABLETS 300/NOS | $150.0K | 3 |
| ATAZOR R 300/100MG TABLET 30S WTC (ATAZANAVIR & RITONAVIR USP TABLETS 300/100MG), Pack Size 1 X 30 | $150.0K | 3 |
| PHARMACEUTICAL PRODUCTS FINISHED GOODS ATAZOR R 300 100 MG TABLET 30S ATAZANAVIR RITONAVIR TABLETS 300 100MG | $100.0K | 2 |
Emcure Pharmaceuticals Limited exports 110 distinct Atazanavir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - ATAZOR R 300/100 with 6 shipments worth $300.0K.
Regulatory Requirements: Exporting Atazanavir to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Atazanavir to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Atazanavir Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $11.3M | 226 | 55 | $50.0K |
| 2 | EMCURE PHARMACEUTICALS LIMITED ★ | $8.0M | 159 | 48 | $50.0K |
| 3 | HETERO LABS LIMITED | $2.1M | 43 | 5 | $50.0K |
| 4 | EMCURE PHARMACEUTICALS LTD | $400.0K | 8 | 6 | $50.0K |
Emcure Pharmaceuticals Limited ranks #2 among 17 Indian Atazanavir exporters. Average shipment value of $50.0K compared to the market average of $1.3M. The closest competitors by value are MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Atazanavir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 163 | 34.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 133 | 28.1% |
| NHAVA SHEVA SEA (INNSA1) | 29 | 6.1% |
| Bombay Air | 25 | 5.3% |
| JNPT | 15 | 3.2% |
| JNPT/ NHAVA SHEVA SEA | 15 | 3.2% |
| HYDERABAD ACC (INHYD4) | 12 | 2.5% |
| Bombay Air Cargo | 9 | 1.9% |
What Other Antiviral & HIV Medications Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Atazanavir Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Atazanavir, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atazanavir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atazanavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 167 individual customs records matching Emcure Pharmaceuticals Limited exporting Atazanavir, covering 110 formulations to 53 countries via 67 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 88+ countries, 199+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atazanavir Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Atazanavir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Atazanavir Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atazanavir. For current shipment-level data, contact TransData Nexus.